Search

everythinglearnresearchcommunity

for

Search:↓

The new FDA labeling rules provide more detailed drug safety information for pregnant and breastfeeding women, but more data is needed on the risks of many dermatologic drugs.

Topical finasteride helps regrow hair and reduce hair loss in men and women.

Finasteride doesn't effectively treat hair loss in postmenopausal women.

Helmets used in acupuncture and light therapy can affect brain blood flow, hair growth, and may improve brain diseases and cognitive functions.

Gene therapy in mice increased lifespan and improved health without causing cancer.

Finasteride caused long-term sexual and non-sexual side effects in young men with hair loss.

Keratinocytes and adipose-derived stem cells can effectively heal difficult skin wounds.

Advancements in male reproductive medicine are ongoing, but more research and improved treatments are needed in several areas.

Hormonal therapies are safe and effective for treating adult women's acne.

Non-hormonal treatments should be used first for sexual dysfunction in postmenopausal breast cancer patients on aromatase inhibitors, with hormones as a second option.

After chemotherapy for a gestational trophoblastic tumor, normal pregnancy rates are possible, but there's a slightly higher risk of the tumor reoccurring in future pregnancies.

The document concludes that non-operative treatment for gender dysphoria is safe and effective, and hormone therapy does not increase cancer risk.

Postmenopausal ovary stromal cells have a unique makeup and limited steroid production, suggesting androgens come from the adrenal gland.

Antimalarial agents are effective for LPP, and intralesional steroids are effective for FFA.

The European Society of Endocrinology advises individualized long-term management for PCOS, focusing on lifestyle changes, accurate diagnosis, and treatments for associated health risks and symptoms.

After menopause, women lose a lot of skin collagen, but estrogen replacement might improve skin health.

Severe acne in a young girl may indicate underlying hormonal issues.

New treatments for skin and hair disorders in women of color address unique biological differences and include specific acne medications, sunscreens, skin lighteners, and hair care adjustments.

Lifestyle changes improve metabolism and fertility in overweight PCOS patients; anti-obesity drugs show potential but need more research.

Biologic therapies can cause various adverse events, but allergy/immunology clinicians can manage them.

Natural volatiles and essential oils have health benefits and can enhance the effects of some medicines, but more research is needed to understand how they work and their possible side effects.

Testosterone increases sexual behavior in female capuchin monkeys.

The Random Forest algorithm was the most accurate at diagnosing Polycystic Ovarian Syndrome.

Myo-inositol and D-chiro-inositol improve hormonal and physical symptoms in teenage girls with PCOS.

Cyproterone acetate is a safe treatment that causes mild feminizing effects and is more effective with added estrogens.

High levels of anti-Müllerian hormone can indicate polycystic ovarian syndrome in women who can have babies.

High levels of Anti-Müllerian Hormone (AMH) in the blood can strongly predict Polycystic Ovarian Syndrome (PCOS) and related issues in women of reproductive age.

Monitoring potassium levels is important for women taking spironolactone.

Low iron levels are linked to hair loss in women.

Children and adults with Cushing's disease show different symptoms and males have more severe cases; surgery outcomes can be predicted by certain factors.